ENTITY

Cellid (299660 KS)

23
Analysis
Health Care • South Korea
Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.
more
bullish•Danal Co Ltd
•11 Apr 2022 15:18

KOSDAQ 150 Rebalancing in June: Safely Tradable Names for Position Buildups at This Point

This post screens the tradable stocks for Long/Short position buildups for the KOSDAQ 150 rebalancing, which will occur on the second Thursday in...

Logo
556 Views
Share
bullish•GOLFZON
•27 Mar 2022 15:21

KOSDAQ150 Index Rebalance Preview (June): Potential Inclusions Starting to Outperform

With 80% of the review period complete, there are 15 potential index changes. The potential inclusions have started to outperform the index and the...

Logo
663 Views
Share
bullish•Nexon GT Co Ltd
•27 Mar 2022 06:02

KOSDAQ150 Rebalance in June 2022 Amid Ongoing War in Ukraine

We discuss the potential additions and deletions in the upcoming June 2022 KOSDAQ150 rebalance. The ongoing war in Ukraine has impacted the...

Logo
522 Views
Share
bullish•Enchem
•17 Feb 2022 07:00

Potential Additions and Deletions to KOSDAQ150 Rebalance in June 2022

We discuss the potential additions and deletions in the upcoming June 2022 KOSDAQ150 rebalance. The top 10 potential inclusions are on average down...

Logo
486 Views
Share
bullish•WYSIWYG Studios
•06 Jan 2022 05:08

KOSDAQ150 Index Rebalance Preview (June 2022): Lots of Changes Early in the Review Period

A third of the way through the review period, we see 14 potential changes to the KOSDAQ150 Index at the June rebalance. A reversal in performance...

Logo
698 Views
Share
x